---
mi_id: MIPR-node_86a79ea
type: press_release
canonical_url: "https://www.pheonixresearch.com/agriculture-agritech/seeds/press-release/soybean-seed-4-12-per-cent-a-third-on-expired-patents-84-per-cent-of-brazil-hectares-uncertified/"
md_url: "https://www.pheonixresearch.com/agriculture-agritech/seeds/press-release/soybean-seed-4-12-per-cent-a-third-on-expired-patents-84-per-cent-of-brazil-hectares-uncertified.md"

schema:
  "@type": NewsArticle
  "@id": MIPR-node_86a79ea
  url: "https://www.pheonixresearch.com/agriculture-agritech/seeds/press-release/soybean-seed-4-12-per-cent-a-third-on-expired-patents-84-per-cent-of-brazil-hectares-uncertified/"
  title: "Soybean Seed Grew 4.12 Per Cent With USD 3.90 Billion of Its Value on Expired Patents — and 84 Per Cent of Brazil's New Hectares Were Sown With Seed Nobody Bought"
  description: "Global soybean seed market USD 12.60 billion in 2025 to USD 17.40 billion by 2033, a 4.12% CAGR. USD 3.90 billion, 31 per cent, sits on patents that expired in 2010, and 84.4 per cent of Brazil's new hectares were sown with uncertified seed."
  datePublished: "2026-11-16T12:56:57+00:00"
  dateModified: "2026-11-16T14:33:36+00:00"
  keywords:
    - soybean seed market
    - soybean seed market size
    - Brazil soybean seed royalties
    - saved soybean seed
    - Enlist E3
    - XtendFlex
    - soybean seed forecast 2033
    - Cultive Biotec
    - Vylor
    - Bayer soybean
  isPartOf:
    - id: MISG-node_281f4aa
      type: CollectionPage
      url: "https://www.pheonixresearch.com/agriculture-agritech/seeds/"
      name: Seeds
    - id: MIIN-node_25bc9e9
      type: CollectionPage
      url: "https://www.pheonixresearch.com/agriculture-agritech/"
      name: "Agriculture & Agritech"
    - id: MIWS-root
      type: WebSite
      url: "https://www.pheonixresearch.com/"
      name: Pheonix Research

acf:
  phoenix_meta_title: "Soybean Seed Market 2026-2033: USD 12.60bn to USD 17.40bn at 4.12% — a Third Priced on Expired Patents"
  phoenix_meta_description: "Global soybean seed market USD 12.60 billion in 2025 to USD 17.40 billion by 2033, a 4.12% CAGR. USD 3.90 billion, 31 per cent, sits on patents that expired in 2010, and 84.4 per cent of Brazil's new hectares were sown with uncertified seed."

global_schema:
  organization:
    "@id": MIWS-root#organization
    "@type": Organization
    url: "https://www.pheonixresearch.com/"
    name: Pheonix Research
  website:
    "@id": MIWS-root
    "@type": WebSite
    url: "https://www.pheonixresearch.com/"
    name: Pheonix Research
  api:
    "@id": MIWS-root#api
    "@type": WebAPI
    url: "https://www.pheonixresearch.com/"

graph:
  node_id: MIPR-node_86a79ea
  graph_node_endpoint: "https://graph.pheonixresearch.com/api/v1/query/live/node/MIPR-node_86a79ea"
  graph_snapshot: "https://graph.pheonixresearch.com/api/v1/read/live/graph"
  graph_exclusions: "https://graph.pheonixresearch.com/api/v1/read/live/exclusions"
  graph_meta: "https://graph.pheonixresearch.com/api/v1/read/live/meta"
  graph_bundle: "https://graph.pheonixresearch.com/api/v1/read/live/bundle"

discovery:
  discovery_json: "https://www.pheonixresearch.com/.well-known/pheonix-discovery.json"
  llms_txt: "https://www.pheonixresearch.com/llms.txt"
  sitemap: "https://www.pheonixresearch.com/sitemap.xml"
---
# Soybean Seed Grew 4.12 Per Cent With USD 3.90 Billion of Its Value on Expired Patents — and 84 Per Cent of Brazil's New Hectares Were Sown With Seed Nobody Bought

## Soybean seed is the second-largest crop seed market in the world, and a third of it is priced on a claim that has already lapsed

We size the global soybean seed market at **USD 12.60 billion in 2025, rising to USD 17.40 billion by 2033 — a 4.12 per cent CAGR**. That base year is **16.1 per cent** of the USD 78.40 billion global seed market, which makes soybean the second-largest single-crop seed market after corn and roughly **half corn's value on 1.29 times its seed tonnage**.

Two facts sit underneath that number, and neither of them is in the forecast.

The first is that **USD 3.90 billion — 31.0 per cent of the 2025 market — sits on herbicide-tolerance traits whose original patents have expired.** Roundup Ready 1's patent expired in 2010. Roundup Ready 2 has since lapsed. The value did not go with them, because in soybean the royalty is attached to a package rather than to a patent: certified germplasm, a current trait, seed treatment, service and the legal right to plant. It is the package the grower buys. In Brazil that arrangement is now in front of the Supreme Federal Court, with judgment expected in 2026. No other seed market in the world has a third of its value resting on an expired claim.

The second is that **84.4 per cent of the hectares Brazil added over four seasons were sown with seed nobody bought.** Soybean area rose from about 40.9 million hectares in 2021/22 to 48.6 million in 2025/26, an increase of **18.8 per cent**. Over the same four seasons, the area sown with *uncertified* seed rose from 3.1 million hectares to 9.6 million — a 3.1-fold increase, and 19.8 per cent of the current crop, on CropLife Brasil data. Of the 7.7 million hectares Brazil added, 6.5 million went to saved or pirated seed. Certified area grew **3.2 per cent in four years**, across a crop that grew 18.8.

The industry calls this a royalty collection problem. It is more accurate to call it the loss of the incremental hectare.

## The decomposition, with its basis named

Value grows 4.12 per cent a year. Commercial seed volume grows **1.19 per cent**, from 5.55 to 6.10 million tonnes. Value per tonne rises from **USD 2,270 to USD 2,852** — 25.6 per cent, or 2.89 per cent a year. Value per planted hectare rises from **USD 96.9 to USD 120.0**, 23.8 per cent, which is 2.70 per cent a year against implied area growth of about 1.4 per cent.

The report states the split as roughly **29 per cent volume and 71 per cent price, mix and trait content**. That is a log decomposition of the two endpoints: ln(1.0119) divided by ln(1.0412) gives **29.3 / 70.7**, and it reproduces exactly. An endpoint bridge over the same table gives three terms and also closes, on the USD 4,800 million of growth:

 | Term |  | USD million |  | Share of the increase |

 | Commercial volume, 5.55 to 6.10 million tonnes at the 2025 price |  | 1,248.5 |  | 26.0% |

 | Value per tonne, USD 2,270 to USD 2,852 at 2025 volume |  | 3,230.1 |  | 67.3% |

 | Interaction |  | 320.1 |  | 6.7% |

 | **Total increment, 12,600 to 17,400** |  | **4,798.7** |  | **100.0%** |

Both bases are defensible. They are not the same number, and a reader is entitled to know which is being quoted. **Neither 71 nor 67 is a price change.** Both describe what share of the increase is arithmetic rather than demand.

The forecast path is deliberately uneven at the front. **2026 is the softest year at 3.2 per cent**, and it is soft for a reason that has nothing to do with seed demand, before settling into the low-to-mid fours as trait replacement in the Americas and commercial conversion in Asia do the work. On a 2026 base of USD 13.00 billion, the remaining seven years compound at **4.25 per cent** — the weak first year is doing real work in a headline that reads 4.12.

## What the hectare arithmetic says about the volume line

 | Brazil, four seasons |  | 2021/22 |  | 2025/26 |  | Change |

 | Soybean area, million hectares |  | 40.9 |  | 48.6 |  | +18.8% |

 | Uncertified seed area, million hectares |  | 3.1 |  | 9.6 |  | 3.1-fold |

 | Certified seed area, million hectares |  | 37.8 |  | 39.0 |  | +3.2% |

 | Uncertified share of the crop |  | 7.6% |  | 19.8% |  | +12.2 points |

 | Hectares added, million |  | 7.7 |  | of which 6.5 uncertified, 84.4% |

This is why the report models commercial volume at 1.19 per cent rather than at par with area, and it is the structural difference between soybean and every other seed market in this cluster.

A grower who plants saved hybrid corn gets a visibly worse plant, and knows it. A grower who saves a self-pollinating soybean variety gets, agronomically, something very close to what he planted — there is no hybrid vigour to lose and no inbreeding depression to punish him. **Soybean seed has no biological lock on repurchase. Every repeat purchase is either a legal requirement or an economic choice.** That is the whole of the growth story, and it is why the growth rate here is 4.12 per cent against corn's 4.60 and hybrid seed's 6.06 — five basis points above the slowest market in the portfolio and well below everything else in it.

## The collection mechanism, priced

Brazil runs two routes to the same money. Buy certified seed and the technology is embedded in the price, with practitioners putting the royalty component at about **2.6 per cent** of seed cost. Save seed and the grower must file an *Anexo XIX* declaration at the Ministry of Agriculture, produce the prior season's purchase invoice and pay a boleto of **R$270 to R$284 per hectare** before harvest. Do neither, and if technology is detected in the delivered load, the industry retains **7.5 per cent of the grain** — the *multa na moega*, the fine at the elevator.

On the report's own figures that fine is worth about **R$644 a hectare** — 7.5 per cent of 66 sacas at R$2.17 a kilogram of grain — against R$277 of paperwork, a **2.3-fold** premium for non-compliance collected after harvest. The report describes the gap as "roughly double"; the arithmetic gives 2.3 times, and this release uses the arithmetic.

That 7.5 per cent is widely described as a royalty. It is not. It is a fine, and the distinction is precisely what is being litigated.

Four competitors own the collection layer jointly. **Cultive Biotec**, formed by Bayer, BASF, Corteva and Syngenta, administers soybean royalty collection in Brazil; its field consultants work the receiving units directly and its reference productivity in Rio Grande do Sul is **66 sacas per hectare**. Bayer's Pré-Certifica programme signed up **more than 25,000 growers across more than 1 million hectares** in that state in a single season, and the company's soybean lead stated publicly that certified purchase or legal saved seed costs about half the post-planting royalty charged at the elevator — an unusually candid admission that the enforcement price, not the product price, has been setting the grower's perception of value.

The grower's economics have moved the other way. Aprosoja Brasil puts the exchange ratio at about **2.5 kilograms of soybeans per kilogram of seed up to 2015 and 6 to 7 kilograms now** — a 2.6-fold deterioration, with biotechnology royalties inside the seed price identified as the driver. CropLife Brasil puts annual losses to soybean seed piracy at approximately **R$10 billion**.

## The leader shrank in a growing market. The number two chose to.

 | Company |  | Relevant FY2025 figure |  | Change |

 | Bayer AG, about 29% of world value |  | Seed and Traits revenue EUR 11,136m, of which corn EUR 7,149m |  | Soybean about −8% |

 | Vylor (Corteva Seed & Genetics), about 14.9% |  | Soybean seed net sales USD 1,878m; total seed USD 9,898m |  | −3% (price and mix +2%, volume −4%, currency −1%) |

 | Syngenta, about 8% |  | Group seeds sales USD 4.8bn |  | Brazil +17%, North America −12% |

 | Brazilian and Argentine independents, about 18% |  | GDM, TMG, Brasmax, Don Mario and the regional tier |  | Larger share of Brazilian certified volume than of world value |

 | Vylor net royalty position |  | About USD 120m of net royalty expense at year end |  | USD 90m improvement; neutrality targeted 2026 |

 | Corteva to Bayer settlement |  | USD 610m cash, largely Q1 2026 |  | Multi-year freedom to operate |

Bayer is the largest supplier at about **29 per cent** of world value, built on the Monsanto soybean franchise and now carried by the XtendFlex platform and the HT4 tolerance trait it licensed to Corteva in the 2025 settlement. **Its soybean revenue fell about 8 per cent in a year when the market grew 4.12** — and it fell in the Americas, where its share is highest. That is either a technology-cycle trough that XtendFlex and HT4 will reverse, or a structural share loss to licensed competitors. The 2026 and 2027 disclosures settle it, and it is the single most consequential competitive question in this market.

Vylor — Corteva's seed and genetics business, separated on **1 October 2026** — is second at **USD 1,878 million** of soybean seed net sales, 14.9 per cent of the market, and it is deliberately trading brand share for licensed share. It cut net royalty expense by about USD 90 million to roughly **USD 120 million**, expects **royalty neutrality in 2026** two years ahead of plan, and targets **USD 1 billion of net royalty income by 2035**. It paid Bayer **USD 610 million in cash** for the freedom to operate that makes the strategy runnable — 5.1 times its entire annual net royalty expense, funded from one year of free cash flow.

Syngenta is third at roughly 8 per cent on group seed sales of USD 4.8 billion, and it is the clearest case of a global player whose soybean outcome is decided by one national market: Brazil up 17 per cent, North America down 12 and restructuring. Beneath the three sit the Brazilian and Argentine independents, holding an estimated 18 per cent of world value and a much larger share of Brazilian certified volume. Their importance is not their size. They are the channel through which out-licensing actually reaches the grower, which is why Vylor's strategy can work at all.

**Two reporting facts that will be read wrongly, and should not be.** Bayer's soybean seed and traits sales *doubled* in the first quarter of 2026 on a currency- and portfolio-adjusted basis, and **EUR 448 million** of that came from the Corteva licensing agreement — the settlement working through the P&L as revenue, not demand, and annualising it inflates any forecast. And the top two holding roughly 44 per cent of world value is high by seed-industry standards and low against corn's 60 per cent, not because this market is fragmented but because the value is delivered through local germplasm that a global breeding programme cannot replicate cheaply.

## Where the growth is: share of value against share of growth

 | Segment |  | 2025, USD billion |  | Share of value |  | CAGR to 2033 |  | Share of the increase |

 | GM and biotech-stacked seed |  | 11.20 |  | 88.9% |  | 3.95% |  | 84.5% |

 | Conventional non-GM and food-grade seed |  | 1.40 |  | 11.1% |  | 5.50% |  | 15.5% |

 | **Total** |  | **12.60** |  | **100.0%** |  | **4.12%** |  | **100.0%** |

The two rates blend to the headline exactly in the base year: 11,200 at 3.95 plus 1,400 at 5.50 is 519.4 on 12,600, which is 4.12 per cent. Compounded separately they reach USD 17.42 billion against the 17.40 control — 0.1 per cent over, which is rounding, not a defect.

Non-GM seed is 11.1 per cent of value and **15.5 per cent of the increase**. Its base is not a rejection of biotechnology. It is the food-grade complex — natto, tofu, edamame, high-oleic specialty oil — plus the Asian markets where commercial seed penetration is simply low. It should not be read as a Western premiumisation story.

By *trait position*, which is the split that decides pricing power, proprietary stacked traits hold **USD 7.30 billion, 58.0 per cent**, off-patent glyphosate-only technology **USD 3.90 billion, 31.0 per cent**, and non-GM germplasm 11.1 per cent. By end use, commodity crush is 82.0 per cent, food-grade and specialty 14.0, forage and cover crop 4.0.

## Geography: the Americas hold 88.9 per cent, and the two halves monetise a hectare differently

 | Region |  | 2025, USD billion |  | Share |  | CAGR to 2033 |

 | North America |  | 5.65 |  | 44.8% |  | — |

 | of which: United States |  | 5.34 |  | 42.4% |  | — |

 | South America |  | 5.55 |  | 44.0% |  | — |

 | of which: Brazil |  | 3.95 |  | 31.3% |  | — |

 | of which: Argentina |  | 1.15 |  | 9.1% |  | — |

 | Asia-Pacific |  | 0.95 |  | 7.5% |  | 5.4% |

 | Europe |  | 0.32 |  | 2.5% |  | — |

 | Middle East & Africa |  | 0.13 |  | 1.0% |  | — |

 | **Total** |  | **12.60** |  | **100.0%** |  | **4.12%** |

The five regions sum to USD 12.60 billion exactly. The United States alone is **42.4 per cent of world value on 26 per cent of world area**, which is the ratio that matters: US soybean seed costs **USD 63.05 per planted acre** on USDA Economic Research Service data, nearly all of it certified, nearly all carrying a current trait stack, and much of it carrying seed-applied chemistry. No other market monetises a soybean hectare that way.

Put the two halves on the same denominator and the report's central tension becomes arithmetic. USD 63.05 per acre is **USD 155.8 per planted hectare**; Brazil's USD 3.95 billion across 48.6 million hectares is **USD 81.3**. **A soybean hectare in the United States is monetised at 1.9 times the rate of a soybean hectare in Brazil.** The report states the Brazilian figure as "roughly 40 per cent below" the American; the hectare arithmetic gives **48 per cent** below, and this release uses 48.

Asia-Pacific is the fastest-growing region at **5.4 per cent**, which compounds to USD 1.45 billion by 2033 and **10.4 per cent of the market's entire increase** — from a base where most seed never enters a commercial channel. China is about USD 0.60 billion and India about USD 0.28 billion, and together with a Chinese area of roughly 10 million hectares growing mostly saved or public varieties, they are the clearest measure of the monetisation gap this market still contains. Europe is the only region where non-GM is the default rather than the exception, and is consequently a food-grade market rather than a technology market.

## The forecast is a legal question before it is an agronomic one

Three court actions are live in Brazil, and each is about the same thing — whether a payment survives the patent that justified it.

The first challenges collection on Roundup Ready 1 technology after its patent expired in **2010**, and the elevator mechanism with it. The first-instance decision went against collection; Bayer won on appeal at the Rio Grande do Sul court and at the Superior Court of Justice; the growers' federation is seeking review at the **Supreme Federal Court, with judgment expected in 2026**. The second, filed in 2013, challenges an arrangement tied to Roundup Ready 2 that required growers to waive rights over post-patent royalties. The third, filed in 2015, disputes collecting Intacta RR2 PRO royalties at more than one point in the chain and challenges contractual clauses as abusive.

Alongside the litigation, Congress is considering a reform that would do two things at once, and the two outcomes point in opposite directions.

- The reform widens the base. It would extend royalty collection to germplasm on saved seed — today a grower saving seed pays only for the biotechnology of transgenic varieties, while genetic-improvement royalties are paid once at purchase under a model in force since 1997 — and it would make seed piracy a crime punishable by up to a year's imprisonment and a fine. Abrasem puts genetic-improvement royalties at 7.7 per cent of the cost of a commercial soybean seed. This is the largest single upside in the forecast, and it is a structural change rather than a price change.

- The court narrows it. Appellate courts have twice upheld collection, so the direction of travel at appellate level is with the industry. But the constitutional question is unresolved, and USD 3.90 billion sits on that tranche. A ruling against post-patent collection would not remove the germplasm value; it would remove the pricing basis for a third of the market and force a rapid repricing onto current-generation traits.

The report's own downside is stated plainly: **if the court rules against collection and the congressional reform fails in the same legislative cycle, 4.12 per cent becomes a flat market.** That combination — not any technology launch, not any acreage number — is what would do it.

## Why the technology does not rescue the rate

The trait ladder has reached a three-way stack. **Enlist E3** combines 2,4-D choline, glyphosate and glufosinate tolerance; **Conkesta E3** adds insect protection to the same herbicide base; XtendFlex extends tolerance to dicamba, though the US dicamba vacatur removed a degree of freedom from that platform and weighed on Bayer's cotton business in 2025. The 2025 Bayer-Corteva settlement, which cost Corteva **USD 610 million** in cash, bought multi-year clarity on technology access and included access to Bayer's **HT4** trait — which Corteva has stated plainly is not royalty-free.

The single most informative number in the technology chapter is not a yield gain. It is **Argentina's penetration of more than 30 per cent with Enlist E3, achieved almost entirely through out-licensing** inside one normal technology cycle. Where the licence is priced to move and offered to independent seed houses, a South American soybean market converts quickly. That is the mechanism Vylor is now running deliberately.

What the technology does not do is raise the growth rate much. US soybean yields have improved at roughly **half a bushel per acre per year** over the long run, so the premium for a new stack has to be justified against a smaller increment than in corn — and where the benefit is herbicide flexibility rather than yield, the value case is agronomic convenience, which is the first thing a grower economises on when margins compress. Gene editing will produce a proprietary soybean product inside the window, most likely in oil quality and most likely launched in the Americas; it will not move the global value pool before 2033, and a plan that requires it to is a plan that misses. Regulation (EU) 2026/1388, adopted 17 June 2026, in force 16 July 2026 and applying from **17 July 2028**, creates a separate pathway for certain new genomic techniques — which matters to soybean as a precedent, not as a market.

The technology that actually determines this market's growth rate is not a gene. It is the enforcement technology: the strip test at the receiving unit that tells a buyer whether the load in front of him was grown from a bag that was paid for. And that is a product problem before it is a legal one — a grower who saves seed for three seasons has left the market as a customer, and getting him back requires a yield advantage large enough to beat a free alternative.

## What the model assumes, and where it breaks

2026 is the softest year in the forecast at 3.2 per cent, for a reason that is not seed demand: Brazilian growers are carrying high interest rates, sharply higher production costs and, in Rio Grande do Sul, an indebtedness problem serious enough that seed companies in the state expect to sell only **80 to 82 per cent of the volume they produce** against an ideal of 85 per cent, after 75 per cent the previous season, with margins described as practically zero after interest costs. Soybean seed oversupply reached **30 to 40 per cent in 2024/25**, described by the Brazilian soybean seed producers' association as unprecedented. Because soybean seed cannot hold commercial quality into the next season, surplus must be sold as grain: a 60-kilogram bag that sells for R$220 as seed returns about R$130 as grain, and the multiplier absorbs the R$90 spread.

There is a second-order risk that is easy to miss. Multipliers collect royalties at the point of sale and must remit them onward. Where a financially distressed multiplier does not, the grower can be billed a second time at the elevator on delivery — which converts a counterparty credit problem in the smallest companies in the chain into a grower relations problem for the largest.

Concentration is the other structural exposure: **42.4 per cent of world value in one country**, with US plantings at 87.3 million acres in 2024, 81.2 million in 2025 and 84.7 million intended for 2026 — a 6 per cent swing in two years in the market that carries nearly half the value. Brazil's 2026/27 area of **49.3 million hectares, up 1.4 per cent**, is the slowest expansion in twenty years against a five-year average of 4.2 per cent.

## Scope, boundaries and how the base year was built

The 2025 base year is a disclosed triangulation, not a licensed study, and three independent methods were reconciled. **Top-down**, soybean as a 16.1 per cent share of the USD 78.40 billion global seed market, with the share set from crop-level seed value shares across the six largest field crops. **Bottom-up**, disclosed tier-1 soybean revenue — principally Vylor's USD 1,878 million — the soybean component of Bayer Seed and Traits after stripping corn and non-soybean lines, Syngenta's USD 4.8 billion across all crops, plus the Brazilian and Argentine independent tier and disclosed national certified-seed volumes. **Per hectare**, seed cost applied to national area: USD 63.05 per planted acre against 84.7 million US acres, Brazilian certified and royalty costs against 49.3 million hectares, Argentine costs against 17.6 million hectares, at 50 to 60 kilograms of seed per hectare. The three converge in a **USD 12.0 to 13.2 billion band**; the midpoint is taken.

Four boundary calls are worth stating explicitly, because each of them is a place where a reader could reasonably double-count this market.

- Volume is commercial, purchased seed only — 5.55 million tonnes, not total seed sown. Soybean seed rate varies with row spacing, maturity group and region, and a total-sown tonnage would describe agronomy rather than a market.

- The USD 3.90 billion off-patent tranche is a modelled allocation between proprietary stacks and glyphosate-only technology, not a disclosed figure, and is presented as such.

- The elevator retention is a fine, not a royalty. The distinction is the litigation, not a definitional nicety.

- This market is not additive with the USD 78.40 billion global seed market, of which soybean is 16.1 per cent, nor with the corn, rice, vegetable, hybrid, seed treatment, GM/biotech or forage and turf reports in the same cluster. Trait fees embedded in seed price are counted here; chemistry sold separately is not.

## Further reading

- Brazil's Soybean Area Grew 18.8 Per Cent. Its Certified Seed Area Grew 3.2 Per Cent. — the four-season hectare arithmetic underneath the lowest CAGR in Pheonix's seeds coverage.

- A Third of the Soybean Seed Market Rests on Patents That Expired in 2010 — the USD 3.90 billion, and the Brazilian royalty case now before the Supreme Federal Court.

## Related research

- Global Seed Market Report, Size, Share and Forecast 2026–2033 — the USD 78.40 billion hub of which soybean is 16.1 per cent.

- Global Corn (Maize) Seed Market Report — the market soybean is most often compared with, and the comparison that explains the five basis points between 4.12 and 4.60.

- Global Genetically Modified and Biotech Seeds Market Report — the trait layer, of which soybean is the largest single application.

- Global Seed Treatment Market Report — the most accessible increment in a soybean bag, and the one that needs neither a regulatory approval nor a breeding cycle.

- Global Hybrid Seeds Market Report — the 6.06 per cent comparator, and the market where the biological lock on repurchase actually exists.

- Global Vegetable Seeds Market Report, Global Rice Seed Market Report and Global Forage and Turf Grass Seed Market Report — the rest of the crop-seed tier.

- Global Crop Protection Market Report — the chemistry side of the trait stack, and the market in which glyphosate's price collapse is measured.

- Colombia Soybean Grain Market and Global Animal Feed Market Report — the crush and meal demand that underwrites the replacement cycle, on the grain side of the boundary this report draws.

**Read the full market report:** [Global Soybean Seed Market Report, Size, Share and Forecast 2026–2033](https://www.pheonixresearch.com/agriculture-agritech/seeds/market-report/global-soybean-seed-market/) — the full methodology, the segmentation by technology and trait position, the five regional chapters and the royalty-collection analysis this release draws on.

## About this report

*Global Soybean Seed Market Report, Size, Share and Forecast 2026–2033* sizes the market at USD 12.60 billion in 2025 rising to USD 17.40 billion by 2033, a 4.12% CAGR, on commercial seed volume of 5.55 million tonnes growing 1.19% a year. It covers segmentation by technology, trait position, end use and distribution channel; regional analysis across North America, South America, Asia-Pacific, Europe and Middle East & Africa; the competitive set including Bayer, Vylor, Syngenta and the Brazilian and Argentine independent tier; the royalty collection layer; and the regulatory and litigation position in Brazil, the United States, Argentina, China, India and the European Union. Figures are nominal USD, and the soybean entity is mapped to Wikidata Q11006.

## About Pheonix Research

Pheonix Research publishes market intelligence built on triangulated primary data and a signal engine that scores evidence rather than aggregating published estimates. Our reports state their method, disclose where their figures diverge from the published range, and name the boundary of every market they size. Research, data and methodology enquiries can be directed through the contact form on [pheonixresearch.com](https://www.pheonixresearch.com/).
